DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
HUMAN GENE THERAPY SUBCOMMITTEE 
MINUTES OF MEETING^ 
July 30, 1990 
The Human Gene Therapy Subcommittee (a subcommittee of the 
Recombinant DNA Advisory Committee) was convened at 9:00 a.m. on 
July 30, 1990, in Building 31C, Conference Room 6, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 
20892. Dr. LeRoy Walters (Chair) presided. In accordance with 
Public Law 92-463, the meeting was open to the public. The 
following were present for all or part of the meeting: 
Subcommittee Members: 
Judith Areen 
Michael Brewer 
James F. Childress 
Charles Epstein 
Martin F. Gellert 
Brigid Leventhal 
Maurice Mahoney 
R. Scott Mclvor 
Abbey Meyers 
Richard Mulligan 
Robert Murray 
Robertson Parkman 
LeRoy Walters 
Doris Zallen 
Nelson A. Wivel 
(Executive Secretary) 
A subcommittee roster is attached (Attachment) . 
Ad hoc consultant: 
Gerard McGarrity, Coriell Institute for Medical Research 
Liaison representatives: 
Charles MacKay, National Institutes of Health 
Charles McCarthy, National Institutes of Health 
Henry Miller, DHHS Food and Drug Administration 
National Institutes of Health staff: 
Cindy Able, NCI 
Paul Aebersold, NCI 
W. French Anderson, NHLBI 
Florence Antoine, NCI 
Kim Badenhop, NCI 
^The Human Gene Therapy Subcommittee is advisory to the Recombinant DNA 
Advisory Committee, and its recommendations should not be considered as final 
or accepted. The Office of Recombinant DNA Activities should be consulted for 
NIH policy on specific issues. 
[56] 
Recombinant DNA Research, Volume 14 
